Jean–Louis Fischel

Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity.

M C Etienne, S. Chéradame, Jean–Louis Fischel et al. · Journal of Clinical Oncology · 1995 · 284 citations

Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: Establishment, characterization and response to cytotoxic treatment

J Gioanni, Jean–Louis Fischel, Jean-Claude Lambert et al. · European Journal of Cancer and Clinical Oncology · 1988 · 200 citations

Tumor Innervation, Medicine, Pathology +7

Influence of epidermal growth factor receptor (EGFR), p53 and intrinsic MAP kinase pathway status of tumour cells on the antiproliferative effect of ZD1839 (‘Iressa’)

Nicolas Magné, Jean–Louis Fischel, A Dubreuil et al. · British Journal of Cancer · 2002 · 156 citations · Full text

Activation of nuclear factor kappaB through the IKK complex by the topoisomerase poisons SN38 and doxorubicin: a brake to apoptosis in HeLa human carcinoma cells.

Virginie Bottero, V. Busuttil, Agnès Loubat et al. · PubMed · 2001 · 133 citations

Chemoprevention Strategy, Apoptosis, Cell Death +19

Role of the HER2 [Ile655Val] genetic polymorphism in tumorogenesis and in the risk of trastuzumab-related cardiotoxicity

S. Beauclair, Patricia Formento, Jean–Louis Fischel et al. · Annals of Oncology · 2007 · 118 citations · Full text

Trastuzumab-related Cardiotoxicity, Pathology, Immune-related Gene Polymorphism +6